Clinical trial
Evaluation of 1-Year Clinical Outcomes With Early Inclisiran Initiation in Post-MI Patients
NCT07142265 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of 1-Year Clinical Outcomes With Early Inclisiran Initiation in Post-MI Patients
- Lead sponsor
- Novartis Pharmaceuticals
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 30, 2025
- Completion date
- September 30, 2027
- Enrollment
- 300 (estimated)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.